Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.10.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HG.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.323NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.323NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.323NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FU.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FU.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FN.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FN.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.74NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JB.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDK.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.58NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
BA.2.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.58NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
BA.4.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used